Literature DB >> 33936281

Chemical hemorrhagic cystitis: Diagnostic and therapeutic pitfalls (Review).

Razvan-Cosmin Petca1,2, Razvan-Ionut Popescu1,2, Cristian Toma1,2, Mihai Cristian Dumitrascu3,4, Aida Petca3,5, Florica Sandru6,7, Calin Bogdan Chibelean8,9.   

Abstract

Chemical cystitis (CC) is an inflammation of the bladder caused by various chemical agents ingested intentionally or accidentally. It is linked to chemotherapeutic agents such as cyclophosphamide, therapeutic agents for diverse diseases, and anesthetic agents consumed abusively for recreational effects such as ketamine, or can be linked to environmental and surrounding factors such as soaps, gels, spermicides, and dyes. CC is a pathology with an increasing incidence that is inadequately treated due to its infectious cystitis-like symptoms. The hemorrhagic form can have a rampant evolution. Treatment options of CC and its complications are under continuous research with no accepted standardized sequence. In many situations, the treatments are difficult to obtain, administer, and follow-up. In addition, the lack of experience of the physician may pose other obstacles in delivering treatment to the patient. In conclusion, CC is a disease with an increasing incidence, challenging to diagnose, which is frequently mistreated, and has multiple treatment modalities that still require standardization in administration and sequencing.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  chemical cystitis; hematuria; hemorrhagic cystitis; intravesical therapy; noninfectious cystitis; urinary bladder inflammation

Year:  2021        PMID: 33936281      PMCID: PMC8082586          DOI: 10.3892/etm.2021.10056

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  70 in total

1.  Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration.

Authors:  J Trotman; I Nivison-Smith; A Dodds
Journal:  Bone Marrow Transplant       Date:  1999-04       Impact factor: 5.483

2.  Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its development.

Authors:  R Buchbinder; A Forbes; F Kobben; I Boyd; R M Snow; J J McNeil
Journal:  J Clin Epidemiol       Date:  2000-10       Impact factor: 6.437

3.  Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.

Authors:  I Martin-Suarez; D D'Cruz; M Mansoor; A P Fernandes; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

4.  Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.

Authors:  L N Turkeri; L G Lum; J P Uberti; E Abella; F Momin; C Karanes; L L Sensenbrenner; G P Haas
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

5.  Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis.

Authors:  J Miller; G D Burfield; K L Moretti
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

Review 6.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-03-22       Impact factor: 20.096

7.  Protective Effect of Intravesical Platelet-Rich Plasma on Cyclophosphamide-Induced Hemorrhagic Cystitis.

Authors:  E Ozyuvali; M E Yildirim; T Yaman; B Kosem; O Atli; E Cimentepe
Journal:  Clin Invest Med       Date:  2016-12-01       Impact factor: 0.825

8.  Hemorrhagic cystitis due to intravesical instillation of gentian violet completely recovered with conservative therapy.

Authors:  Se Joong Kim; Dong Hee Koh; Jung Seun Park; Hyun Soo Ahn; Jong Bo Choi; Young Soo Kim
Journal:  Yonsei Med J       Date:  2003-02       Impact factor: 2.759

Review 9.  Natural therapeutics for urinary tract infections-a review.

Authors:  Sarita Das
Journal:  Futur J Pharm Sci       Date:  2020-09-18

Review 10.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675

View more
  2 in total

1.  C-Reactive Protein: More than a Biomarker.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2021-09-01       Impact factor: 7.111

2.  Oral Preparation of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin (Ialuril® Soft Gels) for the Prevention of LUTS after Intravesical Chemotherapy.

Authors:  Celeste Manfredi; Lorenzo Spirito; Francesco Paolo Calace; Raffaele Balsamo; Marco Terribile; Marco Stizzo; Lorenzo Romano; Luigi Napolitano; Gianluigi Califano; Luigi Cirillo; Giovanni Maria Fusco; Claudia Rosati; Carmelo Quattrone; Carmine Sciorio; Massimiliano Creta; Nicola Longo; Marco De Sio; Davide Arcaniolo
Journal:  Pathophysiology       Date:  2022-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.